Corrigendum to ‘The role of hybrid PET/CT in the evaluation of patients with cervical cancer’ [Gynecologic Oncology 100 (2005) 65–69] (The role of hybrid PET/CT in the evaluation of patients with cervical cancer (2006) 100(1) (65–69), (S0090825805006050), (10.1016/j.ygyno.2005.07.013));The role of hybrid PET/CT in the evaluation of patients with cervical cancer

Gynecologic Oncology

Volumn 100, Issue 1, 2006, Pages 65-69

  Amit, Amnon ^a   Beck, Dan ^a   Lowenstein, Lior ^a   Lavie, Offer ^b   Bar Shalom, Rachel ^a   Kedar, Zohar ^a   Israel, Ora ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

^b CARMEL MEDICAL CENTER   (Israel)

Author keywords

Cervical cancer; Detection; FDG; Hybrid PET CT; Treatment

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DEVICE; DIAGNOSTIC ACCURACY; DRUG UPTAKE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; METASTASIS; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; REMISSION; SAMPLE SIZE; SENSITIVITY AND SPECIFICITY; TREATMENT PLANNING; TUMOR VOLUME; UTERINE CERVIX CANCER; WHOLE BODY TOMOGRAPHY;

EID: 29144506286     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2020.07.001     Document Type: Erratum

References (19)

1. E.E. Kim Whole-body positron emission tomography and positron emission tomography/computed tomography in gynecologic oncology Int. J. Gynecol. Cancer 14 1 2004 12 22
2. T. Beyer, D.W. Townsend, and T.M. Blodgett Dual-modality PET/CT tomography for clinical oncology Q. J. Nucl. Med. 46 1 2002 24 34
3. D. Grisaru, B. Almog, C. Levine, U. Metser, A. Fishman, and H. Lerman The diagnostic accuracy of 18F-fluorodeoxyglucose PET/CT in patients with gynecological malignancies Gynecol. Oncol. 94 3 2004 680 684
4. M.J. Reinhardt, C. Ehritt-Braun, D. Vogelgesang, C. Ihling, S. Hogerle, and M. Mix Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET Radiology 218 3 2001 776 782
5. P.W. Grigsby, F. Dehdashti, and B.A. Siegel FDG-PET evaluation of carcinoma of the cervix Clin. Positron. Imaging 2 2 1999 105 109
6. P.G. Rose, L.P. Adler, M. Rodriguez, P.F. Faulhaber, F.W. Abdul-Karim, and F. Miraldi Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study J. Clin. Oncol. 17 1 1999 41 45
7. P. Pisani, D.M. Parkin, F. Bray, and J. Ferlay Erratum: estimates of the worldwide mortality from 25 cancers in 1990 Int. J. Cancer 83 6 1999 870 873
8. P.G. Rose, B.N. Bundy, E.B. Watkins, J.T. Thigpen, G. Deppe, and M.A. Maiman Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer N. Engl. J. Med. 340 15 1999 1144 1153
9. W.A. Peters III, P.Y. Liu, R.J. Barrett II, R.J. Stock, B.J. Monk, and J.S. Berek Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix J. Clin. Oncol. 18 8 2000 1606 1613
10. A. Sedlis, B.N. Bundy, M.Z. Rotman, S.S. Lentz, L.I. Muderspach, and R.J. Zaino A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group Study Gynecol. Oncol. 73 2 1999 177 183
11. L.D. Flay, and J.H. Matthews The effects of radiotherapy and surgery on the sexual function of women treated for cervical cancer Int. J. Radiat. Oncol. Biol. Phys. 31 2 1995 399 404
12. G.H. Fletcher Predominant parameters in the planning of radiation therapy of carcinoma of the cervix Bull. Cancer 66 5 1979 561 572
13. P.J. Eifel Accurate diagnosis of regional metastasis from cervical cancer: is PET the answer? Int. J. Radiat. Oncol. Biol. Phys. 59 3 2004 637 638
14. S.S. Gambhir, J. Czernin, J. Schwimmer, D.H. Silverman, R.E. Coleman, and M.E. Phelps A tabulated summary of the FDG PET literature J. Nucl. Med. 42 5 Suppl. 2001 1S 93S
15. P.D. Shreve, Y. Anzai, and R.L. Wahl Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants Radiographics 19 1 1999 61 77
16. L.S. Yeh, Y.C. Hung, Y.Y. Shen, C.H. Kao, C.C. Lin, and C.C. Lee Detecting para-aortic lymph nodal metastasis by positron emission tomography of 18F-fluorodeoxyglucose in advanced cervical cancer with negative magnetic resonance imaging findings Oncol. Rep. 9 6 2002 1289 1292
17. T. Belhocine, A. Thille, V. Fridman, A. Albert, L. Seidel, and P. Nickers Contribution of whole-body 18FDG PET imaging in the management of cervical cancer Gynecol. Oncol. 87 1 2002 90 97
18. W.C. Lin, Y.C. Hung, L.S. Yeh, C.H. Kao, R.F. Yen, and Y.Y. Shen Usefulness of (18)F-fluorodeoxyglucose positron emission tomography to detect para-aortic lymph nodal metastasis in advanced cervical cancer with negative computed tomography findings Gynecol. Oncol. 89 1 2003 73 76
19. P.W. Grigsby, A.K. Singh, B.A. Siegel, F. Dehdashti, J. Rader, and I. Zoberi Lymph node control in cervical cancer Int. J. Radiat. Oncol. Biol. Phys. 59 3 2004 706 712